Is there a generic for Prochlorperazine?

Yes. The FDA Orange Book lists 3 approved generic (ANDA) applications for Prochlorperazine, referencing the brand COMPAZINE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Prochlorperazine?

COMPAZINE (NDA 011127, GLAXOSMITHKLINE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Prochlorperazine are approved?

Prochlorperazine is approved in the following dosage form: suppository.

FDA Orange Book · active-ingredient family

Prochlorperazine

Prochlorperazine is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:COMPAZINE · NDA 011127

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · suppository

Product	Applicant	Application	TE	Approved
COMPAZINERLD×3	GLAXOSMITHKLINE	NDA 011127	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

Product	Applicant	Application	TE	Approved
PROCHLORPERAZINE×3	ABLE	ANDA 040407	—	Jul 11, 2001
COMPRO	PADAGIS US	ANDA 040246	AB	Jun 28, 2000
PROCHLORPERAZINE	COSETTE PHARMS NC	ANDA 040058	AB	Nov 24, 1993

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Prochlorperazine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo